TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 34,889 | 29,887 | 30,582 |
Financial expenses | 116 | 103 | 104 |
Earnings before taxes | 5,415 | 2,861 | 2,693 |
EBITDA | 6,994 | 4,230 | 3,743 |
Total assets | 29,380 | 27,737 | 21,673 |
Current assets | 15,121 | 13,143 | 13,705 |
Current liabilities | 7,173 | 5,201 | 5,933 |
Equity capital | 15,247 | 12,790 | 11,700 |
- share capital | 2,475 | 2,693 | 2,744 |
Employees (average) | 212 | 184 | 175 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 51.9% | 46.1% | 54.0% |
Turnover per employee | 165 | 162 | 175 |
Profit as a percentage of turnover | 15.5% | 9.6% | 8.8% |
Return on assets (ROA) | 18.8% | 10.7% | 12.9% |
Current ratio | 210.8% | 252.7% | 231.0% |
Return on equity (ROE) | 35.5% | 22.4% | 23.0% |
Change turnover | 7,423 | -129 | -890 |
Change turnover % | 27% | 0% | -3% |
Chg. No. of employees | 28 | 9 | 4 |
Chg. No. of employees % | 15% | 5% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.